Sort   by:  
 Page size 
MetabolomicsMetabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease

BACKGROUND: One-third of inflammatory bowel disease (IBD) patients show no response to infliximab (IFX) induction therapy, and approximately half of patients responding become unresponsive over time. Thus, identification of potential treatment response biomarkers are of great cl...

2022-01-13 | MTBLS239 | MetaboLights
UnknownNovel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity.
Not available
S-EPMC5419082 | biostudies-literature
UnknownDecreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations.
Not available
S-EPMC7675974 | biostudies-literature
UnknownRenal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study.
Not available
S-EPMC5034954 | biostudies-literature
UnknownPancrustacean Evolution Illuminated by Taxon-Rich Genomic-Scale Data Sets with an Expanded Remipede Sampling.
Not available
S-EPMC6684935 | biostudies-literature
ProteomicsSubtyping of cardiac amyloidosis by mass spectrometry-based proteomics of endomyocardial biopsies
Cardiac amyloidosis is a severe clinical condition leading to restrictive cardiomyopathy and heart failure. With increasing options for specific treatment of different cardiac amyloid diseases, correct amyloid subtyping is essential for clinical outcome. Mass spectrometry-based methods for cardiac a...
ORGANISM(S): Homo sapiens (Human) 
2022-10-27 | PXD033168 | Pride
Subtyping Proteomics Endomyocardial biopsies Mass spectrometry Cardiac amyloidosis 
ProteomicsSubtyping of cardiac amyloidosis by mass spectrometry-based proteomics of endomyocardial biopsies
Additional data to PXD033168 Cardiac amyloidosis is a severe clinical condition leading to restrictive cardiomyopathy and heart failure. With increasing options for specific treatment of different cardiac amyloid diseases, correct amyloid subtyping is essential for clinical outcome.
ORGANISM(S): Homo sapiens (Human) 
2026-09-21 | PXD047125 | Pride
Proteomics Endomyocardial biopsies Mass spectrometry Cardiac amyloidosis Subtyping 
UnknownEvaluation of a digital entomological surveillance planning tool for malaria vector control: Three country mixed methods pilot study.
Not available
S-EPMC11892875 | biostudies-literature
UnknownEntomological Adaptive Sampling Framework (EASF) for malaria vector surveillance: an economic evaluation of pilot implementation in Ghana and Mozambique.
Not available
S-EPMC13647601 | biostudies-literature
UnknownThe 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A.
Not available
S-EPMC4604478 | biostudies-literature
Sort   by:  
 Page size